FANATREX | Fanatrex

NDC 43093-105-01 Rx only FusePaq™ FANATREX™ (gabapentin 25 mg/mL, in oral suspension - kit) FusePaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP). Description: This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin.  This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient. Contents:

Suggested Preparation Gabapentin, 25 mg/mL oral suspension

1    Remove and Inspect the Contents of the Kit Remove kit contents. Ensure that seals are present and intact on the gabapentin and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.

2    Prepare for Mixing Wear gloves and eye protection during mixing operations. Remove the seal from the oral suspension bottle. Break the seal and remove the cap from the gabapentin bottle.

3    Transfer Gabapentin to the Suspension Bottle Uncap the suspension bottle. Using the included funnel, carefully transfer the gabapentin powder to the suspension bottle. Cap the suspension bottle and mix thoroughly by inverting and shaking until all contents are dissolved. Uncap the suspension bottle. Pour a small amount of the mixed suspension back into the gabapentin bottle. Cap the gabapentin bottle and shake to ensure that all residual gabapentin has been dissolved. Pour the liquid through the funnel into the suspension bottle. Discard the funnel and gabapentin powder bottle.

4    Complete the Mixing Process Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times. Visually ensure that all contents are dissolved.

5    Re-label the Suspension Label the mixed suspension as required for prescription products. Ensure that the original oral suspension vehicle label is removed or obscured, since the original label is no longer accurate once the suspension is prepared.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 15-30°C (59-86°F). The mixed suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies.

Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test. An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.

U.S. Patents Pending

Manufactured by: Fusion Pharmaceuticals, LLC 768 Calle Plano Camarillo, CA 93012

CS75-A1 rev 0

Do not use if safety seal is broken Gabapentin 1-(Aminomethyl)cyclohexaneacetic acidCAS #60142-96-3CAUTION: For manufacturing, processing, repacking, or prescription compounding Net contents: 10.5 g Repackaged by Fusion Pharmaceuticals, LLCCamarillo, CA 93012 CS73-A1 rev 0

Do not use if safety seal is brokenFor Prescription Compounding Only Oral Suspension Vehicle Dye and paraben free Ingredients: water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate Net Contents: 420 mL (14.2 fl oz) Manufactured for:Fusion Pharmaceuticals, LLCCamarillo, CA 93012 CS74-A1 rev 0

Do not use if safety seal is broken NDC 43093-105-01 Rx only FusePaq™  Kit for Oral SuspensionFanatrex™(gabapentin 25 mg/mL, in oral suspension - kit) Description: This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin. This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient. Active Ingredient:

Inactive Ingredients:

CAUTION: For manufacturing, processing, repacking, or presciption compounding. Federal law prohibits dispensing without prescription. U.S. Patents Pending CS72-A1 rev 0

Manufacturer

Diffusion Pharmaceuticals LLC

Active Ingredients

Source

• U.S. National Library of Medicine
• DailyMed
• Last Updated: 4 May 2013